Skip to the content
  • Our Company
    • Management Team
    • Board Members
    • Events
  • Our Approach
  • Partner
  • Careers
  • Resources
  • News
Menu
  • Our Company
    • Management Team
    • Board Members
    • Events
  • Our Approach
  • Partner
  • Careers
  • Resources
  • News
  • Contact
Menu
  • Contact

Nimble Therapeutics spins out of Roche, saving Madison jobs

read more
Path 3
  • News
  • May 6, 2019

A new drug discovery and development company is taking root in Madison, and it will prevent more than a dozen skilled scientists here from losing their jobs.

Nimble Therapeutics formed in April, spun out of Roche Sequencing Solutions, originally NimbleGen Systems, which is slated to close by June 2020.

Read more

PreviousRoche Spinout Nimble Therapeutics Bags $10M to Find New Peptide Drugs
NextAntibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.
PreviousRoche Spinout Nimble Therapeutics Bags $10M to Find New Peptide Drugs
NextAntibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact
  • Our Company
  • Our Approach
  • Partner
  • Careers
  • Resources
  • Contact

603 Science Dr
Madison, WI, USA 53711

LinkedIn
  • Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech
    Read More